Skip to main content
. 2021 Sep 3;36(11):4226–4234. doi: 10.1111/jocs.15962

Table 3.

Rehospitalization (values are presented as mean ± SD and n (%))

Rehospitalization Patients (n = 2340) % (per patient) Event protocol
Necessary rehospitalization
Severe pericardial effusion 19 0.8 1A
Severe pleural effusion 24 1.0 2A, 2B
Heart rhythm disorders 33 1.4 3A, 3B, 3C
Cardiac ischemia 8 0.3 4
Stroke 5 0.2 5
Renal failure 10 0.4 6
Cardiac decompensation 18 0.7 7
INR value disorder 6 0.2 15B
COVID‐19 infection 5 0.2 8
Sternal/wound healing problem 16 0.6 9A
n (total) 144 6.1
Prevention of unnecessary repeat admissions*
Severe pain % (per RME)
Hypertensive attack 2228 2.8 10
Low blood pressure 687 0.9 11A
Severe dyspnea 294 0.4 11B
Asymptomatic pericardial and pleural 576 0.7 12
Effusions 242 0.3 1B
Secretion at the wound site 191 0.2 9B
Lower extremity edema 14,822 0.2 13
Allergic reaction 332 0.02 14
Sinus tachycardia 198 0.4 3B
Atrial fibrillation 106 0.2 3A
INR value disorder 0.1 15A
n (total) 5024 6.3

Abbreviations: COVID‐19, coronavirus disease 2019; INR, International Normalized Ratio (for prothrombin time); RME, Remote Medical Evaluation of Telemedicine Team; SD, standard deviation.

*

More than one medical event in the same patient was included in the calculation.